DK1642897T3 - Alpha crystal form of strontium ranelate, process for its preparation and pharmaceutical compositions containing them - Google Patents

Alpha crystal form of strontium ranelate, process for its preparation and pharmaceutical compositions containing them

Info

Publication number: DK1642897T3
Authority: DK; Denmark
Prior art keywords: preparation; pharmaceutical compositions; compositions containing; crystal form; strontium ranelate
Prior art date: 2004-09-30

Application number

DK05291297T

Other languages

Danish (da)

Inventor

Stephane Horvath

Isabelle Demuynck

Gerard Damien

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-30

Filing date

2005-06-17

Publication date

2009-01-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34942420&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1642897(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-06-17 Application filed by Servier Lab filed Critical Servier Lab

2009-01-26 Application granted granted Critical

2009-01-26 Publication of DK1642897T3 publication Critical patent/DK1642897T3/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Fodder In General (AREA)
Steroid Compounds (AREA)

DK05291297T 2004-09-30 2005-06-17 Alpha crystal form of strontium ranelate, process for its preparation and pharmaceutical compositions containing them DK1642897T3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0410335A FR2875807B1 (en)	2004-09-30	2004-09-30	ALPHA CRYSTALLINE FORM OF STRONTIUM RANELATE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

Publications (1)

Publication Number	Publication Date
DK1642897T3 true DK1642897T3 (en)	2009-01-26

Family

ID=34942420

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05291297T DK1642897T3 (en)	2004-09-30	2005-06-17	Alpha crystal form of strontium ranelate, process for its preparation and pharmaceutical compositions containing them

Country Status (42)

Country	Link
US (2)	US7459568B2 (en)
EP (2)	EP1944302A1 (en)
JP (2)	JP2006104184A (en)
KR (1)	KR100816590B1 (en)
CN (1)	CN100391956C (en)
AP (1)	AP1930A (en)
AR (1)	AR049395A1 (en)
AT (1)	ATE411308T1 (en)
AU (1)	AU2005202718B2 (en)
BR (1)	BRPI0502228A (en)
CA (1)	CA2508824C (en)
CO (1)	CO5710195A1 (en)
CR (1)	CR7876A (en)
CY (1)	CY1108797T1 (en)
DE (1)	DE602005010359D1 (en)
DK (1)	DK1642897T3 (en)
EA (1)	EA008474B1 (en)
EC (1)	ECSP055859A (en)
ES (1)	ES2314593T3 (en)
FR (1)	FR2875807B1 (en)
GE (1)	GEP20074106B (en)
GT (1)	GT200500130A (en)
HK (1)	HK1086260A1 (en)
HR (1)	HRP20080652T3 (en)
IL (1)	IL169237A (en)
MA (1)	MA27815A1 (en)
MX (1)	MXPA05006407A (en)
NO (1)	NO333948B1 (en)
NZ (1)	NZ540802A (en)
OA (1)	OA13013A (en)
PA (1)	PA8638201A1 (en)
PE (1)	PE20060364A1 (en)
PL (1)	PL1642897T3 (en)
PT (1)	PT1642897E (en)
RS (1)	RS51110B (en)
SA (1)	SA05260168B1 (en)
SG (1)	SG121035A1 (en)
SI (1)	SI1642897T1 (en)
TW (1)	TWI367881B (en)
UA (1)	UA80008C2 (en)
WO (1)	WO2006035122A1 (en)
ZA (1)	ZA200504937B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2875807B1 (en) *	2004-09-30	2006-11-17	Servier Lab	ALPHA CRYSTALLINE FORM OF STRONTIUM RANELATE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
US20070292535A1 (en) *	2006-06-19	2007-12-20	Tabbiner Philip S	Strontium compositions and methods of treating arthritic and or osteoporitic conditions
US20070292529A1 (en) *	2006-06-19	2007-12-20	Tabbiner Philip S	Strontium compositions and methods of treating osteoporotic conditions
CN101206208B (en) *	2006-12-19	2011-08-10	北京德众万全药物技术开发有限公司	Method for analyzing strontium ranelate raw material and preparation thereof by HPLC method
WO2010034806A1 (en) *	2008-09-29	2010-04-01	Ratiopharm Gmbh	Anhydrate and hydrate forms of strontium ranelate
IT1398542B1 (en) *	2010-03-05	2013-03-01	Chemelectiva S R L	PROCESS FOR THE PREPARATION OF A POLIMORFO
CN102241663B (en) *	2010-05-10	2013-02-13	山东方明药业集团股份有限公司	Preparation method of strontium ranelate octohydrate
WO2012143932A1 (en) *	2011-04-21	2012-10-26	Shilpa Medicare Limited	Crystalline strontium ranelate form-s
CZ2011320A3 (en)	2011-05-30	2012-12-12	Zentiva, K.S.	Stable crystalline form of X strontium renelate
EP2530068A1 (en)	2011-05-31	2012-12-05	Lacer, S.A.	New strontium salts, synthesis and use thereof in the treatment of osteoporosis
US9301945B2 (en)	2011-07-21	2016-04-05	Emory University	Methods for treating inflammatory conditions and states, and cancers by antagonizing NF-κB activation
CN102503931A (en) *	2011-09-20	2012-06-20	浙江华海药业股份有限公司	Preparation method for strontium ranelate crystalline form H
WO2013113319A1 (en) *	2012-01-31	2013-08-08	Pharmathen S.A.	Process for the preparation of strontium ranelate, intermediate or hydrates thereof
EP2641905A1 (en)	2012-03-23	2013-09-25	Urquima S.A.	Solid forms of strontium ranelate and processes for their preparation
US8569514B1 (en)	2012-05-17	2013-10-29	Divi's Laboratories, Ltd.	Process for the preparation of strontium ranelate

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2651497B1 (en) *	1989-09-01	1991-10-25	Adir	NOVEL SALTS OF BIVALENT METALS OF N, N-DI ACID (CARBOXYMETHYL) AMINO-2 CYANO-3 CARBOXYMETHYL-4 CARBOXY-5 THIOPHENE, THEIR PREPARATION METHOD AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ZA956029B (en)	1994-07-22	1997-01-20	Lilly Co Eli	Combination treatment for inhibiting bone loss
FR2749759B1 (en) *	1996-06-17	1999-11-26	Adir	USE OF STRONTIUM SALTS FOR THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ARTHROSIS
DE19642451A1 (en)	1996-10-15	1998-04-16	Merck Patent Gmbh	Aminothiophene carboxamides
JP2005504818A (en) *	2001-10-03	2005-02-17	テバファーマシューティカルインダストリーズリミティド	Preparation of levofloxacin and its forms
AU2003223158B2 (en) *	2002-01-09	2008-01-17	Emisphere Technologies, Inc.	Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
WO2004012739A1 (en) *	2002-08-06	2004-02-12	Teva Pharmaceutical Industries Ltd.	Novel crystalline forms of gatifloxacin
FR2844797B1 (en) *	2002-09-24	2004-10-22	Servier Lab	NEW PROCESS FOR THE INDUSTRIAL SYNTHESIS OF ACID TETRAESTERS 5- [BIS (CARBOXYMETHYL)] - 3-CARBOXYMETHYL-4-CYANO-2- THIOPHENECARBOXYLIC AND APPLICATION TO THE SYNTHESIS OF BIVALENT HYDERS OF RANELATES ACID
FR2844795B1 (en) *	2002-09-24	2004-10-22	Servier Lab	NEW PROCESS FOR THE INDUSTRIAL SYNTHESIS OF STRONTIUM RANELATE AND ITS HYDRATES
FR2844796A1 (en) *	2002-09-24	2004-03-26	Servier Lab	New methyl 5-amino-4-cyano-3-(2-methoxy-2-oxoethyl)-2-thiophene-carboxylate useful as intermediate in the preparation of ranelic acid, its strontium, calcium or magnesium salts
FR2875807B1 (en) *	2004-09-30	2006-11-17	Servier Lab	ALPHA CRYSTALLINE FORM OF STRONTIUM RANELATE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

2004
- 2004-09-30 FR FR0410335A patent/FR2875807B1/en not_active Expired - Fee Related
2005
- 2005-05-24 PE PE2005000574A patent/PE20060364A1/en not_active Application Discontinuation
- 2005-05-26 MA MA28300A patent/MA27815A1/en unknown
- 2005-05-27 GT GT200500130A patent/GT200500130A/en unknown
- 2005-05-30 CA CA002508824A patent/CA2508824C/en not_active Expired - Fee Related
- 2005-05-31 US US11/140,822 patent/US7459568B2/en not_active Expired - Fee Related
- 2005-05-31 AP AP2005003323A patent/AP1930A/en active
- 2005-06-02 OA OA1200500169A patent/OA13013A/en unknown
- 2005-06-14 AR ARP050102423A patent/AR049395A1/en not_active Application Discontinuation
- 2005-06-15 MX MXPA05006407A patent/MXPA05006407A/en active IP Right Grant
- 2005-06-15 SA SA05260168A patent/SA05260168B1/en unknown
- 2005-06-15 CR CR7876A patent/CR7876A/en not_active Application Discontinuation
- 2005-06-16 IL IL169237A patent/IL169237A/en not_active IP Right Cessation
- 2005-06-16 CN CNB2005100753929A patent/CN100391956C/en not_active Expired - Fee Related
- 2005-06-16 CO CO05058754A patent/CO5710195A1/en not_active Application Discontinuation
- 2005-06-16 EC EC2005005859A patent/ECSP055859A/en unknown
- 2005-06-17 ZA ZA200504937A patent/ZA200504937B/en unknown
- 2005-06-17 GE GEAP20058848A patent/GEP20074106B/en unknown
- 2005-06-17 EP EP08007270A patent/EP1944302A1/en not_active Withdrawn
- 2005-06-17 UA UAA200505970A patent/UA80008C2/en unknown
- 2005-06-17 EA EA200500842A patent/EA008474B1/en not_active IP Right Cessation
- 2005-06-17 SI SI200530490T patent/SI1642897T1/en unknown
- 2005-06-17 PT PT05291297T patent/PT1642897E/en unknown
- 2005-06-17 ES ES05291297T patent/ES2314593T3/en active Active
- 2005-06-17 DK DK05291297T patent/DK1642897T3/en active
- 2005-06-17 SG SG200503938A patent/SG121035A1/en unknown
- 2005-06-17 PL PL05291297T patent/PL1642897T3/en unknown
- 2005-06-17 WO PCT/FR2005/001515 patent/WO2006035122A1/en active Application Filing
- 2005-06-17 BR BRPI0502228-2A patent/BRPI0502228A/en not_active IP Right Cessation
- 2005-06-17 NO NO20052998A patent/NO333948B1/en not_active IP Right Cessation
- 2005-06-17 EP EP05291297A patent/EP1642897B9/en not_active Revoked
- 2005-06-17 RS RSP-2008/0506A patent/RS51110B/en unknown
- 2005-06-17 AT AT05291297T patent/ATE411308T1/en active
- 2005-06-17 DE DE602005010359T patent/DE602005010359D1/en active Active
- 2005-06-17 NZ NZ540802A patent/NZ540802A/en not_active IP Right Cessation
- 2005-06-17 JP JP2005177199A patent/JP2006104184A/en active Pending
- 2005-06-17 TW TW094120331A patent/TWI367881B/en not_active IP Right Cessation
- 2005-06-17 AU AU2005202718A patent/AU2005202718B2/en not_active Ceased
- 2005-07-01 PA PA20058638201A patent/PA8638201A1/en unknown
- 2005-07-08 KR KR1020050061542A patent/KR100816590B1/en not_active IP Right Cessation
2006
- 2006-05-29 HK HK06106187A patent/HK1086260A1/en not_active IP Right Cessation
2008
- 2008-08-12 US US12/228,381 patent/US7745482B2/en not_active Expired - Fee Related
- 2008-11-19 CY CY20081101327T patent/CY1108797T1/en unknown
- 2008-12-16 HR HR20080652T patent/HRP20080652T3/en unknown
2010
- 2010-01-07 JP JP2010001847A patent/JP2010132669A/en active Pending

Also Published As

Publication number	Publication date
PE20060364A1 (en)	2006-06-17
FR2875807A1 (en)	2006-03-31
ES2314593T3 (en)	2009-03-16
MA27815A1 (en)	2006-04-03
TW200610758A (en)	2006-04-01
NZ540802A (en)	2006-11-30
BRPI0502228A (en)	2006-05-09
NO20052998D0 (en)	2005-06-17
TWI367881B (en)	2012-07-11
CA2508824C (en)	2009-03-24
EP1642897B1 (en)	2008-10-15
US7459568B2 (en)	2008-12-02
GEP20074106B (en)	2007-05-10
OA13013A (en)	2006-11-10
ATE411308T1 (en)	2008-10-15
ZA200504937B (en)	2006-04-26
AU2005202718B2 (en)	2010-09-16
EP1642897A1 (en)	2006-04-05
HK1086260A1 (en)	2006-09-15
AP1930A (en)	2008-12-15
PT1642897E (en)	2008-11-27
DE602005010359D1 (en)	2008-11-27
CO5710195A1 (en)	2006-12-29
ECSP055859A (en)	2006-09-18
CR7876A (en)	2007-12-10
PA8638201A1 (en)	2006-05-16
KR20060049966A (en)	2006-05-19
NO20052998L (en)	2006-03-31
AP2005003323A0 (en)	2005-06-30
RS51110B (en)	2010-10-31
MXPA05006407A (en)	2006-04-05
NO333948B1 (en)	2013-10-28
SA05260168B1 (en)	2009-02-25
EA200500842A1 (en)	2006-04-28
FR2875807B1 (en)	2006-11-17
CN100391956C (en)	2008-06-04
SG121035A1 (en)	2006-04-26
JP2010132669A (en)	2010-06-17
IL169237A (en)	2010-12-30
GT200500130A (en)	2005-12-20
CA2508824A1 (en)	2006-03-30
CY1108797T1 (en)	2014-04-09
JP2006104184A (en)	2006-04-20
PL1642897T3 (en)	2009-04-30
US7745482B2 (en)	2010-06-29
EA008474B1 (en)	2007-06-29
US20060069271A1 (en)	2006-03-30
AU2005202718A1 (en)	2006-04-13
EP1944302A1 (en)	2008-07-16
CN1754878A (en)	2006-04-05
AR049395A1 (en)	2006-07-26
KR100816590B1 (en)	2008-03-24
UA80008C2 (en)	2007-08-10
WO2006035122A1 (en)	2006-04-06
HRP20080652T3 (en)	2009-01-31
EP1642897B9 (en)	2009-08-12
US20080312314A1 (en)	2008-12-18
SI1642897T1 (en)	2009-02-28

Publication	Publication Date	Title
DK1752443T3 (en)	2012-10-22	New crystalline form V of agomelatine, process for its preparation and pharmaceutical compositions containing this
DK1896364T3 (en)	2011-02-28	Powdered lime composition, method of preparation thereof and use thereof
DK1667986T3 (en)	2013-05-06	Acetonesolvate of dimethoxydocetaxel and process for its preparation
DK1564202T3 (en)	2008-12-15	A new process for the preparation of and a new crystal form of agomelation and pharmaceutical compositions containing this
DK1707562T3 (en)	2008-10-13	Crystalline v-form of ivabradine hydrochloride, process for its preparation and pharmaceutical compositions containing it
DK1695710T3 (en)	2008-09-22	Crystalline beta-form of ivabradine hydrochloride, process for its preparation and pharmaceutical compositions containing it
DK1642897T3 (en)	2009-01-26	Alpha crystal form of strontium ranelate, process for its preparation and pharmaceutical compositions containing them
DK1695709T3 (en)	2008-09-29	Crystalline gamma-form of ivabradine hydrochloride, process for its preparation and pharmaceutical compositions containing it
DK1913001T3 (en)	2013-10-21	(R) -N-METHYLNALTREXON, METHODS OF SYNTHESIS AND PHARMACEUTICAL APPLICATION
IS7543A (en)	2004-11-22	Benzothiadiazepine derivatives, methods of their manufacture and pharmaceutical compositions containing them
DK3305776T3 (en)	2019-12-09	PYRROL COMPOUNDS AS INHIBITORS OF ERK-PROTEIN KINASES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
DK1695965T3 (en)	2008-12-15	Crystalline beta form of ivabradine hydrochloride, process for its preparation and famceutic compositions containing it
DK2056964T3 (en)	2019-05-06	Hitherto unknown molecular composition, method of preparation thereof and method of application thereof
DK1909764T3 (en)	2014-12-15	Pharmaceutical compositions comprising levetiracetam and process for their preparation
DK1845978T3 (en)	2010-12-13	Substituted pyrazolopyridines, compositions containing them, processes for their preparation, and use thereof
DK1457208T3 (en)	2006-12-11	Process and pharmaceutical compositions for reliably achieving acceptable serum testosterone levels
IS8024A (en)	2005-09-14	Adamantan derivatives, methods of producing them and pharmaceutical compositions containing them
DK2044076T3 (en)	2010-02-01	Process for the preparation of asenapine and intermediate products used in the process
DK2036892T3 (en)	2010-06-07	1,2,4,5-Tetrahydro-3H-benzazepine Compounds, Process for Preparation thereof, and Pharmaceutical Compositions Containing These
DK1720544T3 (en)	2008-07-21	New azabicyclic derivatives, their method of preparation and pharmaceutical compositions containing them
DK1813678T3 (en)	2014-08-11	Process for Preparation of Glycogen
DK2110135T3 (en)	2014-03-31	Pharmaceutical composition for treating depression and method of preparation thereof
DK2038294T3 (en)	2011-03-28	18-methyl-19-nor-androst-4-ene-17,17-spiro ether (18-methyl-19-nor-20-spirox-4-ene-3-one) and pharmaceutical compositions containing these
DK1601363T3 (en)	2012-09-03	Use as a drug of cholest-4-one-3-one derivatives, pharmaceutical compositions containing them and novel derivatives
DK2042497T3 (en)	2010-06-07	Process for the synthesis of strontium ranelate and its hydrates